Polyoma virus middle t antigen: a tumor progression factor.

AUTOR(ES)

Seif, R

RESUMO

Polyoma virus (PyV) deletion mutant dl23 (affecting both large T and middle t but not small t antigens) was used to study transformation of 3T3 rat cells. This mutant generated stable transformants in the agar assay at a frequency similar to that of wild-type virus (WT). However, WT-induced transformants were detected 3 weeks after infection, whereas those induced by the mutant could not be detected until 6 to 8 weeks after infection. In this respect, dl23 PyV behaved like WT simian virus 40 (SV40). Cells transformed by WT SV40 or by dl23 PyV were similar in all their transformed properties. Those transformed by WT PyV were different from the others on the basis of morphology, cell adhesion to the substrate, release of protease activity, efficiency of doubling in agar, growth rate, and time required for tumor formation. Saturation density, the ability to grow in agar, the serum requirement for cloning, and the ability to grow on a cell monolayer were similar for all transformants. Middle t antigen enhanced membrane alterations and growth rate of the transformed cells, shortening the time required for tumor formation in rats.

Documentos Relacionados

• Polyoma virus middle T antigen: relationship to cell membranes and apparent lack of ATP-binding activity.
• Antibodies specific for the polyoma virus middle-size tumor antigen.
• Deletion mapping of a short polyoma virus middle T antigen segment important for transformation.
• Induction of c-jun protooncogene expression and transcription factor AP-1 activity by the polyoma virus middle-sized tumor antigen.
• Expression of biologically active middle T antigen of polyoma virus from recombinant baculoviruses.